beta 2-Microglobulin in cerebrospinal fluid from children with different diseases

Area of Science:

• Pediatric Neurology
• Infectious Diseases
• Biomarker Research

Background:

• Beta 2-microglobulin (B2M) is a protein found on the surface of most nucleated cells.
• Elevated B2M levels in cerebrospinal fluid (CSF) may indicate central nervous system inflammation or infection.
• Understanding B2M's role in pediatric infections is crucial for early diagnosis and management.

Purpose of the Study:

• To investigate the diagnostic utility of CSF beta 2-microglobulin (B2M) concentrations in children.
• To correlate B2M levels with specific infectious agents, particularly viral meningitis.
• To assess the relationship between B2M and albumin in pediatric CSF samples.

Main Methods:

• Prospective study involving 56 children aged 0-12 years.
• Measurement of beta 2-microglobulin (B2M) concentrations in cerebrospinal fluid (CSF).
• Comparison of B2M levels across different diagnostic groups, including viral meningitis, fever of other origin, facial nerve paresis, and sepsis.

Main Results:

• All patients with viral meningitis exhibited B2M levels exceeding 3000 micrograms/l, with a mean of 10.825 micrograms/l.
• The highest B2M concentration (48.096 micrograms/l) was observed in an infant with severe herpes simplex meningitis.
• Elevated B2M levels were noted in some patients with fever of other origin, facial nerve paresis, and sepsis, but were generally lower than in viral meningitis.

Conclusions:

• CSF beta 2-microglobulin (B2M) is a sensitive indicator for viral meningitis in children.
• B2M may serve as a valuable biomarker for identifying serious CNS infections in pediatric patients.
• Further research is warranted to elucidate the precise role and correlation of B2M with albumin in various pediatric neurological conditions.